Live Quote · OTCEVFMHealthcare· Biotechnology

Evofem Biosciences, Inc.

$0.01 9.09%($-0.00)
TickerSpark Score
59/100
Mixed
100
Valuation
50
Profitability
70
Growth
24
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EVFM research report →

52-Week Range37% of range
Low
$0.00
Current
$0.01
High
$0.02
Company Overviewwww.evofem.com

About the company

Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive.

CEO
Saundra Pelletier
IPO
2014
Employees
32
HQ
San Diego, CA, US

Price Chart

-20.00% · this period
$0.02$0.01$0.01Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.06M
P/E
-0.16
P/S
0.05
P/B
-0.01
EV/EBITDA
-17.34
Div Yield
0.00%
Profitability
Gross Margin
74.13%
Op Margin
-17.08%
Net Margin
-29.90%
ROE
8.58%
ROIC
18.31%
Growth & Income
Revenue
$20.18M · 4.23%
Net Income
$391.00K · 104.41%
EPS
$0.00 · 102.39%
Op Income
$1.44M
FCF YoY
48.78%
Performance & Tape
52W High
$0.02
52W Low
$0.00
50D MA
$0.01
200D MA
$0.01
Beta
-1.28
Avg Volume
291.50K

Get TickerSpark's AI analysis on EVFM

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jan 12, 24Zhang Yansell104
Dec 21, 23Kamdar Kim P.sell10
Dec 31, 22File Justin J.other0
Dec 31, 22PELLETIER SAUNDRA Lsell50,000
Apr 13, 23Zhang Yanother0
Aug 2, 22Yip Jenny C.other0
May 31, 22Atkinson Katherine Coccaother0
May 31, 22Atkinson Katherine Coccaother6,667
May 31, 22Atkinson Katherine Coccaother4,000
May 27, 22PELLETIER SAUNDRA Lbuy141,000
Coverage · EVFM

Our EVFM coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on EVFM yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate EVFM report →
Internal Compare

Similar companies

Peers in the same neighborhood.